コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s composed of 13 subunits and is the largest eukaryotic initiation factor.
2 heterogeneous protein complexes such as the eukaryotic initiation factors.
3 complex (TC) with eIF2-GTP, is stimulated by eukaryotic initiation factor 1 (eIF1), eIF1A, eIF3, and
4 ke ER kinase (PERK) and the alpha subunit of eukaryotic initiation factor 2 (eIF-2alpha), as well as
10 repression of the p53 protein by the CUGBP1-eukaryotic initiation factor 2 (eIF2) repressor complex.
12 rotein kinase R (PKR), which inactivates the eukaryotic initiation factor 2 (eIF2) translation initia
14 ludes an early initiation complex containing eukaryotic initiation factor 2 (eIF2), GTP, and methioni
15 an Obg-family GTPase, has been implicated in eukaryotic initiation factor 2 (eIF2)-mediated translati
19 nitiation is regulated by phosphorylation of eukaryotic initiation factor 2 (eIF2-P) that causes decr
20 phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2alpha) and inhibits
21 the phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) in MEFs in an
22 the phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) translation i
28 responses (AADR) such as phosphorylation of eukaryotic initiation factor 2 (p-eIF2) leading to incre
29 t the hepatic heme-regulated inhibitor (HRI)-eukaryotic initiation factor 2 alpha (eIF2 alpha) kinase
30 y converging at serine-51 phosphorylation on eukaryotic initiation factor 2 alpha (eIF2alpha) and act
31 spond to cellular stress by deactivating the eukaryotic initiation factor 2 alpha (eIF2alpha) or othe
33 d by attenuating protein translation through eukaryotic initiation factor 2 alpha (eIF2alpha) phospho
34 In 2014, scientists discovered mutations in eukaryotic initiation factor 2 alpha kinase 4 (EIF2AK4)
35 ation with polysomes likewise depends on the eukaryotic initiation factor 2 alpha kinase 4, which ass
36 at AKT1 protein loss led to the induction of eukaryotic initiation factor 2 alpha subunit (eIF2alpha)
37 which can be repressed by phosphorylation of eukaryotic initiation factor 2 alpha-subunit (eIF2alpha)
38 eatic ER kinase, and its downstream effector eukaryotic initiation factor 2 in human leukemia (HL60)
39 orylation of both protein kinase R (PKR) and eukaryotic initiation factor 2 on the alpha-subunit in s
40 hared across the ages, corroborating similar eukaryotic initiation factor 2 phosphorylation responses
41 ts, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most
42 (ER) cisternae, increased phosphorylation of eukaryotic initiation factor 2 subunit alpha (P-eIF2alph
44 nitiation factor eIF2alpha (alpha subunit of eukaryotic initiation factor 2), ensuring viral protein
45 hosphorylation of the alpha-subunit of eIF2 (eukaryotic initiation factor 2), which inhibits its guan
46 -like ER kinase)-eIF2alpha (alpha subunit of eukaryotic initiation factor 2)-dependent pathway by Sub
48 trol nonderepressible 2), phosphorylation of eukaryotic initiation factor 2, and increased synthesis
49 sphorylation of PKR and the alpha subunit of eukaryotic initiation factor 2, indicating that K1L and
50 ither protein kinase R, which phosphorylates eukaryotic initiation factor 2, nor oligoadenylate synth
51 e in phosphorylation of the alpha subunit of eukaryotic initiation factor 2, requiring PKR-like endop
52 ated PKR phosphorylates the alpha subunit of eukaryotic initiation factor 2, thereby inhibiting prote
53 ated PKR phosphorylates the alpha-subunit of eukaryotic initiation factor 2, thereby inhibiting prote
54 translational control via phosphorylation of eukaryotic initiation factor 2, which is implicated in l
55 suppresses protein synthesis by inactivating eukaryotic initiation factor 2-alpha (eIF2-alpha), to ex
56 st-in-class, small molecule inhibitor of the eukaryotic initiation factor 2-alpha kinase 3 (EIF2AK3)
57 w "privileged" translation despite inhibited eukaryotic initiation factor 2-guanosine triphosphate-in
60 mulate and activate Gcn2p phosphorylation of eukaryotic initiation factor-2 (eIF2) and the general am
61 ly of protein kinases that phosphorylate the eukaryotic initiation factor-2 (eIF2) function in transl
62 t environmental stresses, phosphorylation of eukaryotic initiation factor-2 (eIF2) rapidly reduces pr
65 mal inhibitors enhanced GADD34 stability and eukaryotic initiation factor 2alpha (eIF-2alpha) dephosp
66 to amino acid deficiency, phosphorylation of eukaryotic initiation factor 2alpha (eIF2 approximately
67 kinase 1/2 (ERK1/2 Tyr202/204; +65% +/- 9%), eukaryotic initiation factor 2alpha (eIF2alpha Ser51; -2
68 ed through the translation initiation factor eukaryotic initiation factor 2alpha (eIF2alpha) and the
70 associated with increased phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha) in the l
71 und in solid tumours, activated the upstream eukaryotic initiation factor 2alpha (eIF2alpha) kinase G
72 R kinase (EIF2AK3)], the ER stress-activated eukaryotic initiation factor 2alpha (eIF2alpha) kinase.
73 mbryonic fibroblasts depleted for individual eukaryotic initiation factor 2alpha (eIF2alpha) kinases,
74 dd34 (damage-inducible protein 34) prolonged eukaryotic initiation factor 2alpha (eIF2alpha) phosphor
75 nt study, we investigated whether increasing eukaryotic initiation factor 2alpha (eIF2alpha) phosphor
76 e previously reported that activation of the eukaryotic initiation factor 2alpha (eIF2alpha) stress p
77 a rudimentary amino acid starvation-sensing eukaryotic initiation factor 2alpha (eIF2alpha) stress r
78 asmic reticulum kinase (PERK) phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha) to atten
79 e of several kinases that phosphorylates the eukaryotic initiation factor 2alpha (eIF2alpha) to inhib
80 SNCEE, we found the translational regulator eukaryotic initiation factor 2alpha (eIF2alpha) was hype
81 f the PERK arm stimulates phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha), resulti
82 g and activation through a process requiring eukaryotic initiation factor 2alpha (eIF2alpha), the tra
83 ses often involve chronic phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha), with de
84 nretinide and bortezomib are mediated by the eukaryotic initiation factor 2alpha (eIF2alpha)-ATF4 sig
85 KR)-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2alpha (eIF2alpha)-dependen
86 nize SAMD9 to prevent granule formation in a eukaryotic initiation factor 2alpha (eIF2alpha)-independ
90 dings in this investigation was that PKR and eukaryotic initiation factor 2alpha are phosphorylated u
91 However, Abeta-induced inactivation of the eukaryotic initiation factor 2alpha decreases the synapt
92 ent of its canonical induction downstream of eukaryotic initiation factor 2alpha eIF2alpha phosphoryl
93 However, Abeta-induced inactivation of the eukaryotic initiation factor 2alpha halts the transcript
94 ely, genetically reducing phosphorylation of eukaryotic initiation factor 2alpha in excitatory neuron
95 ed ATF6 translocation and phosphorylation of eukaryotic initiation factor 2alpha in mouse cortical ne
97 general control nonderepressible 2-dependent eukaryotic initiation factor 2alpha phosphorylation and
98 BP1 and G3BP2 cannot form SGs in response to eukaryotic initiation factor 2alpha phosphorylation or e
99 indicative of proliferation such as reduced eukaryotic initiation factor 2alpha phosphorylation, inc
100 ely depleted within a few days, resulting in eukaryotic initiation factor 2alpha phosphorylation, TCR
101 tol-requiring enzyme 1alpha (IRE1alpha), and eukaryotic initiation factor 2alpha phosphorylation.
102 acentas, providing a potential mechanism for eukaryotic initiation factor 2alpha phosphorylation.
104 r protein kinase R, which phosphorylates the eukaryotic initiation factor 2alpha to inhibit global pr
105 t to phosphorylate its substrate, eIF2alpha (eukaryotic initiation factor 2alpha), halting cellular t
107 ulate translation via phosphorylation of the eukaryotic initiation factor 2alpha, and transcription v
108 bles rapid and reversible phosphorylation of eukaryotic initiation factor 2alpha, leading to inhibiti
109 h enables it to phosphorylate its substrate, eukaryotic initiation factor 2alpha, leading to translat
110 in the level of nuclear ATF6, phosphorylated eukaryotic initiation factor 2alpha, nuclear XBP1, and t
111 ylation of the translation initiation factor eukaryotic initiation factor 2alpha, suggesting a novel
112 In addition, increased phosphorylation of eukaryotic initiation factor 2alpha, the translation fac
114 le stress pathways is the phosphorylation of eukaryotic initiation factor 2alpha, which is phosphoryl
115 yzed the effects of NTZ on the regulation of eukaryotic initiation factor-2alpha (eIF2alpha) and its
116 latency is an active process controlled by a eukaryotic initiation factor-2alpha (eIF2alpha) kinase (
117 t results in phosphorylation of the parasite eukaryotic initiation factor-2alpha (eIF2alpha), leading
119 sly shown that phosphorylation of Toxoplasma eukaryotic initiation factor-2alpha (TgIF2alpha) is a co
121 ess marker proteins including phosphorylated eukaryotic initiation factor-2alpha, activating transcri
125 n of eIF2alpha and the subsequent control of eukaryotic initiation factor 2B (eIF2B), a multisubunit
126 , and S536-phosphorylated epsilon subunit of eukaryotic initiation factor 2B [eIF2Bepsilon(S536)] is
129 (T421/S424)-p70S6K phosphorylation and total eukaryotic initiation factor 2Bepsilon (eIF2Bepsilon) pr
130 n 80S ribosomes and diminishes dependence on eukaryotic initiation factor 3 (eIF3) of reinitiation by
131 in some of the bona fide SG markers, such as eukaryotic initiation factor 3 (eIF3) or eIF4A, or the p
133 ation initiation requires the recruitment of eukaryotic initiation factor 3 (eIF3), but also requires
135 ntified the N-terminal 91 amino acids of the eukaryotic initiation factor 3 subunit f (N91-eIF3f) as
136 pression encoded the N-terminal 91 aa of the eukaryotic initiation factor 3 subunit f (N91-eIF3f).
138 ith, and relieves the inhibitory function of eukaryotic initiation factor 3f, a repressive component
139 then applied to quantify phosphorylations on eukaryotic initiation factor 3H (eIF3H), a protein integ
140 aintenance in vivo by specifically targeting eukaryotic initiation factor 4A (eIF4A) and interfering
141 carrying a T-DNA insertion in one of the two eukaryotic initiation factor 4A (eIF4A) genes present in
142 anslation initiation by strongly stimulating eukaryotic initiation factor 4A (eIF4A) helicase activit
144 unwind G4 substrates, reminiscent of that of eukaryotic initiation factor 4A (eIF4A) on double-strand
146 Here we identify the catalytic activity of eukaryotic initiation factor 4A (eIF4A), an ATP-dependen
149 initiation factors involved in 40S scanning (eukaryotic initiation factor 4A [eIF4A], eIF4B, and Ded1
153 ted that knockdown of the EJC core component Eukaryotic initiation factor 4a3 (Eif4a3) results in ful
155 y brain cytoplasmic (BC) RNAs cooperate with eukaryotic initiation factor 4B (eIF4B) to control trans
157 (eIF2alpha Ser51; -20 +/- 5%, P < 0.05) and eukaryotic initiation factor 4E (eIF4E Ser209; +33 +/- 1
159 programs that are sensitive to depletion of eukaryotic initiation factor 4E (eIF4E) and phosphorylat
160 a mediates induction of VEGF expression in a eukaryotic initiation factor 4E (eIF4E) binding protein
161 hosphorylation of p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein
162 ing pathways enhanced polysome occupancy and eukaryotic initiation factor 4E (eIF4E) binding to the 5
168 h, in turn, regulates phosphorylation of the eukaryotic initiation factor 4E (eIF4E) on Ser-209.
172 te the phosphorylation and activation of the eukaryotic initiation factor 4E (eIF4E), a protein that
173 h biotin and an orthosteric inhibitor of the eukaryotic initiation factor 4E (eIF4E), an enzyme invol
174 of Pea enation mosaic virus (PEMV) binds to eukaryotic initiation factor 4E (eIF4E), but how this af
175 importance is the complex between cap-bound eukaryotic initiation factor 4E (eIF4E), eIF4G, and poly
177 ression of constitutively hypophosphorylated eukaryotic initiation factor 4E (eIF4E)-binding protein
178 (CDK1/CYCB1) to directly hyperphosphorylate eukaryotic initiation factor 4E (eIF4E)-binding protein
180 /3 (4EBP), which inhibits the translation of eukaryotic initiation factor 4E (eiF4E)-bound mRNAs.
181 ian capped mRNAs is achieved through the cap-eukaryotic initiation factor 4E (eIF4E)-eIF4G-eIF3-40S c
182 NFAT, and translation factors, specifically eukaryotic initiation factor 4E (elf4E) and S6 ribosomal
183 irways have increased phosphorylation of the eukaryotic initiation factor 4E and its partner the 4E-b
185 ly depends on transcriptional enhancement of eukaryotic initiation factor 4E binding protein (4E-BP)
186 tion of p70 ribosomal S6 kinase (p70s6K) and eukaryotic initiation factor 4E binding protein 1 (4EBP1
187 Thr-308 and Ser-473), S6 kinase 1 (Thr-389), eukaryotic initiation factor 4E binding protein 1 (Thr-3
188 p70 ribosomal protein S6 kinase 1 [S6K1] and eukaryotic initiation factor 4E binding protein 1) and c
189 protein synthesis by inhibition of eIF4EBPs (eukaryotic Initiation Factor 4E Binding Proteins), regul
190 p70 ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding (eIF4E-binding)
191 C1) activation as indicated by a decrease in eukaryotic initiation factor 4E-binding 1 (4E-BP1) phosp
192 mTORC1 signaling through p70S6Ks (S6K1/2) or eukaryotic initiation factor 4E-binding protein (4E-BP1/
193 ence of amino acids increased the binding of eukaryotic initiation factor 4E-binding protein (4EBP1)
194 active mutant of the translational repressor eukaryotic initiation factor 4E-binding protein 1 (4E-BP
195 ever, adult HSCs had more hypophosphorylated eukaryotic initiation factor 4E-binding protein 1 (4E-BP
197 athways of p70 ribosomal S6 kinase (p70S6K), eukaryotic initiation factor 4E-binding protein 1 (4EBP1
198 rEC showed selective increased expression of eukaryotic initiation factor 4E-binding protein 1 (4EBP1
199 d completely suppressed Akt, GSK3beta, mTOR, eukaryotic initiation factor 4E-binding protein 1, and S
200 n of the ribosomal protein S6 kinase and the eukaryotic initiation factor 4E-binding protein 1, two d
201 ng protein interacting protein 2 (Paip2) and eukaryotic initiation factor 4E-binding protein 2 (4E-BP
202 egulator of mRNA translation initiation, the eukaryotic initiation factor 4E-binding protein 2, leads
203 ncrease in ribosomal protein S6 kinase 1 and eukaryotic initiation factor 4E-binding protein-1 (4E-BP
205 ned the expression and distribution of mTOR, eukaryotic initiation factor 4E-binding protein1/2 (4E-B
206 via the phosphorylation and inactivation of eukaryotic initiation factor 4E-binding proteins (4E-BPs
207 is controlled by the translation inhibitors, Eukaryotic initiation factor 4E-binding proteins (4E-BPs
209 3 kinase or blocking the interaction between eukaryotic initiation factors 4E (eIF4E) and 4G (eIF4G)
210 survival programs through the regulation of eukaryotic initiation factor 4F (eIF4F) and ternary comp
211 n, HDAC2 induces the formation of the active eukaryotic initiation factor 4F (eIF4F) complex and indu
213 ion initiation in eukaryotes begins with the Eukaryotic Initiation Factor 4F (eIF4F) complex, made up
215 nce of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulat
216 an replace the cellular cap-binding complex, eukaryotic initiation factor 4F (eIF4F), to mediate tran
217 on of 4E-BP1 and increasing the formation of eukaryotic initiation factor 4F (eIF4F), which promote c
218 itiation complex by the cap-binding complex [eukaryotic initiation factor 4F (eIF4F)] at the 5' end o
219 it enhanced imatinib-mediated inhibition of eukaryotic initiation factor 4F induction, and second, i
221 In mammals, the direct interaction between eukaryotic initiation factor 4G (eIF4G) and eIF3 is thou
222 ings, we show that the eIF4E-binding site in eukaryotic initiation factor 4G (eIF4G) functions as an
223 ty to activate translation and interact with eukaryotic initiation factor 4G (eIF4G) were required to
225 rotein kinase B (PKB) and phosphorylation of eukaryotic initiation factor 4G preceded the rise of MPS
229 initiation scaffold and "ribosome adaptor," eukaryotic initiation factor 4G1 (eIF4G1) in interphase
233 oliovirus (PV) 2A protease (2A(Pro)) cleaves eukaryotic initiation factors 4GI and 4GII (eIF4GI and e
235 large decrease in the amount of hypusinated eukaryotic initiation factor 5A (eIF5A) (1/20 of normal)
242 ) in prokaryotes and a related protein named eukaryotic initiation factor 5B (eIF5B) in eukaryotes.
243 tion was defined by a long residence time of eukaryotic initiation factor 5B (eIF5B) on the 80S ribos
244 ing the last step of translation initiation, eukaryotic initiation factor 5B (eIF5B) promotes the 60S
246 some synthesis by promoting the recycling of eukaryotic initiation factor 6 (eIF6) in a GTP-dependent
249 eading to increased levels of phosphorylated eukaryotic initiation factor alpha, which was required f
250 ightly controlled system that is composed of eukaryotic initiation factors, and which controls the re
251 ion of downstream signaling pathways S6K and eukaryotic initiation factor binding protein 1 (4E-BP1).
252 ied targets of mTORC1 in translation are the eukaryotic initiation factor-binding protein 1 (4E-BP1)
253 and 4E-binding protein; and (4) formation of eukaryotic initiation factor complex 4F, a critical firs
254 ms, their disruption via knockdown of RCK or eukaryotic initiation factor E transporter (eIF4E-T) inc
256 or methionine transfer RNA (Met-tRNAi(Met)), eukaryotic initiation factor (eIF) 2, and guanosine trip
257 protein synthesis via phosphorylation of the eukaryotic initiation factor (eIF) 2alpha and thereby in
258 ly, AMPK activation increased stress-induced eukaryotic initiation factor (eIF) 2alpha phosphorylatio
259 serve to recruit the ribosomal 40S subunit, eukaryotic initiation factor (eIF) 3 and the ternary eIF
263 e PI3K/mammalian target of rapamycin and MYC-eukaryotic initiation factor (eIF) 4E pathways, are pred
267 s have also been directed towards inhibiting eukaryotic initiation factor (eIF) 4F-dependent translat
268 onents of the translation apparatus, such as eukaryotic initiation factor (eIF) 4G (type 2), 40S ribo
269 fect was not due to MNK's known functions as eukaryotic initiation factor (eIF) 4G binding partner or
270 ESs is their ability to bind directly to the eukaryotic initiation factor (eIF) 4G component of the e
271 ranslation; and (iv) LARP1 competes with the eukaryotic initiation factor (eIF) 4G for TOP mRNA bindi
272 zation of the mRNA typically provided by the eukaryotic initiation factor (eIF) 4G/PABP/poly(A) tail
275 ty to phosphorylate the alpha subunit of the eukaryotic initiation factor (eIF)-2 complex, resulting
276 et-tRNAi(Met) in a ternary complex (TC) with eukaryotic initiation factor (eIF)2-GTP scans the mRNA l
277 ease translation of IRE-mRNA in vitro; (iii) eukaryotic initiation factor (eIF)4F binds specifically
278 KAR results in enhanced interaction with the eukaryotic initiation factor (eIF)4G and recruitment of
280 selectively disrupts the interaction between eukaryotic initiation factors (eIF) 4E and 4G, attenuate
283 SGs despite an increased phosphorylation of eukaryotic initiation factor eIF2alpha, a hallmark of st
284 se stresses, different kinases phosphorylate eukaryotic initiation factor eIF2alpha, enabling the tra
285 iciency by modulating the phosphorylation of eukaryotic initiation factor eIF4B, which is critical to
286 which allowed for release and activation of eukaryotic initiation factor eIF4E and subsequent OPN tr
287 pathways and mediate phosphorylation of the eukaryotic initiation factor (eIF4E), a protein that pla
288 , which are known to show high levels of the eukaryotic initiation factor, eIF4E, a potent oncogene.
290 Type I IRESs, 48S complex formation requires eukaryotic initiation factors (eIFs) 1, 1A, 2, 3, 4A, 4B
291 C), consisting of the 40S ribosomal subunit, eukaryotic initiation factors (eIFs) and initiator tRNA
292 translation, requiring only a subset of the eukaryotic initiation factors (eIFs) needed for canonica
295 anced CVB3-induced cleavage of the host cell eukaryotic initiation factor of translation eIF4G in car
296 enzyme system increasing phosphorylation of eukaryotic initiation factor (P-eIF2alpha), which blocks
297 f Plasmodium falciparum eIF2alpha factor, an eukaryotic initiation factor phosphorylated by eIF2alpha
298 omotes dosage-dependent dephosphorylation of eukaryotic initiation factor, potentially inhibiting tra
299 g multiple translation components, including eukaryotic initiation factors, ribosomal large and small
300 r inactivation of the translational molecule eukaryotic initiation factor subunit 2alpha by way of th